Head Of Canadian Cannabis Giant Canopy Growth To Retire At The End Of This FY
Head Of Canadian Cannabis Giant Canopy Growth To Retire At The End Of This FY
Klein, who joined the company in January 2020, led the Ontario-based company through transformation and development to meet opportunities within the global cannabis market.Cannabis company Canopy Growth Corporation (TSX:WEED) (NASDAQ:CGC) announced on Friday that CEO David Klein will retire after the company's current fiscal year ending March 31, 2025.
大麻股公司Canopy Growth Corporation (TSX:WEED) (NASDAQ:CGC)宣布，首席执行官David Klein将在公司截至2025年3月31日的财年结束后退休。
Klein agreed to continue to serve in his role as CEO and as a member of the company's board of directors until this date or such time that a successor is named.
Klein同意在该日期或任何继任者被任命的时候继续担任首席执行官及公司董事会成员。
The Canadian cannabis giant said its board is working on securing a search firm to initiate a CEO selection process focused on identifying the right candidate.
这家加拿大大麻巨头表示，其董事会正在努力寻找一家搜索公司来启动聚焦于寻找合适候选人的首席执行官选拔程序。
Klein, who joined the company in January 2020, led the Ontario-based company through transformation and development to meet opportunities within the global cannabis market.
自2020年1月加入公司以来，Klein带领这家总部位于安大略省的公司转型并开发，以满足全球大麻市场的机遇。
"Under his leadership, the company established a foundation for multi-market cannabis leadership through its transformation to an asset-light model in Canada and across a range of international markets, including Germany," Canopy said in a press release. "In addition, Mr. Klein oversaw the launch and advancement of Canopy USA as a first-of-its-kind structure to offer the Company's shareholders unique exposure to the rapid growth and opportunity presented by the U.S. cannabis market ahead of federal permissibility."
Canopy表示：“在他的领导下，公司通过在加拿大和包括德国在内的一系列国际市场进行变革和发展，为多市场大麻领导地位奠定了基础。此外，Klein先生监督了Canopy USA的推出和发展，这是一种独特的结构，为公司的股东提供了在美国大麻市场上迅速增长和机会之前的独特优势。”
Read Also: Canopy Growth Doubles Down On Its USA Strategy, Announces Exercise of Acreage Options
阅读更多：Canopy Growth在美国策略方面加倍努力，宣布行使Acreage期权
Canopy recently reported a record quarter for Canadian medical marijuana, with new revenue surging 20% year-over-year and representing the 6th consecutive quarter of growth. Achieved gross profit was CA$23 million representing a 67% increase over the first quarter ended June 30, 2023, despite a decline in consolidated net revenue.
Canopy最近报告了一季度加拿大医用大麻的创纪录业绩，新收入同比增长20％，并代表了连续第6个季度的增长。实现的毛利润为2300万加元，在截至2023年6月30日的第一季度上涨了67％，尽管综合净收入下降。
"The fundamentals of our business continue to strengthen, and our focus on profitable revenue generation is yielding clear results as we set the stage for growth in the second half of fiscal 2025," Klein said earlier this month. "With our core businesses delivering adjusted EBITDA profitability and primed for growth, paired with Canopy USA's positioning to benefit from near-term market opportunities in the U.S., Canopy Growth is advancing rapidly and is well established for multi-market cannabis leadership."
Klein这个月早些时候表示：“我们业务的基本面继续加强，我们专注于盈利收入的产生正在产生明显的结果，为我们在2025财年下半年的增长打下基础。随着我们的核心业务实现调整后的EBITDA盈利和为美国市场的短期机会提供利益的Canopy USA的定位，Canopy Growth正在快速发展并为多市场的大麻领导地位做好了充分准备。”
CGC Price Action
CGC股价行为
Canopy's shares traded 0.14%lower at $6.97 per share during the pre-market session on Friday morning.
周五上午的盘前交易中，Canopy的股票价格为每股6.97美元，下跌了0.14％。
Stay tuned here as Canopy moves toward choosing a new CEO.
敬请关注Canopy选择新CEO的消息。
- Canopy Growth Expands U.S. Reach By Acquiring These Two Key Cannabis Brands
- Canopy Growth通过收购这两个关键的大麻品牌扩大了其在美国的影响力
